BioSpace News Archive

SeaStar Medical Holding Corporation, a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that Eric Schlorff, CEO, will present at the Maxim Group Virtual Healthcare Conference hosted by M-Vest on Wednesday, June 21 at 2:30 p.m. Eastern time.

BioLife Solutions, Inc. announced that all of its SciSafe-branded biostorage facilities in the USA have been accredited by the College of American Pathologists.

Fresenius Kabi announced the availability in the United States of Vasopressin Injection, USP, a generic equivalent to Vasostrict®.

DermTech, Inc. announced that ECRI completed its evaluation of the Pigmented Lesion Assay, the foundational assay for the DermTech Melanoma Test, and changed its rating from ‘Inconclusive’ to ‘Somewhat Favorable’.

Aytu BioPharma, Inc. announced Joshua Disbrow, Aytu’s Chief Executive Officer, will participate in a company discussion and host one-on-one meetings with investors at the Healthcare Virtual Conference Part II, presented by Maxim Group LLC and hosted by M-Vest, taking place virtually from June 20-22, 2023.

Hoth Therapeutics, Inc. (NASDAQ: HOTH) today announced today that it has received written approval from the University of Texas MD Anderson Cancer Center Institutional Review Board (IRB) to proceed with its First-in-Human (FIH) Phase 2a clinical trial of HT-001 for the treatment of skin toxicities associated with Epidermal Growth Factor Receptor Inhibitors (EGFRi).

When Vicky Choi began her career as an engineer, she noticed that women and Asian people overall were well represented in the field - but that Asian women weren’t reflected in upper management and leadership positions.

Biodexa Pharmaceuticals PLC announces that at its Annual General Meeting and subsequent General Meeting held earlier , all resolutions put to the Company’s shareholders were duly passed.

NeuBase Therapeutics, Inc. announced that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-20, to be effective as of 5:00 p.m. Eastern Time today, June 14, 2023.

Evoke Pharma, Inc. announced that it will host a key opinion leader webinar on June 22, 2023 at 11:00am ET to discuss the healthcare resource utilization data related to GIMOTI usage presented in a plenary session at DDW 2023 annual conference.